PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31173288-14	2019	Inhibition of miR-128 releases Tropomyosin receptor kinase C (TrkC) from the complementary binding complex, subsequently increasing the protein level of TrkC in GC cells.	mir-128	14-21	neurotrophic receptor tyrosine kinase 3	Homo sapiens	31-60	
31173288-14	2019	Inhibition of miR-128 releases Tropomyosin receptor kinase C (TrkC) from the complementary binding complex, subsequently increasing the protein level of TrkC in GC cells.	mir-128	14-21	neurotrophic receptor tyrosine kinase 3	Homo sapiens	62-66	
31173288-14	2019	Inhibition of miR-128 releases Tropomyosin receptor kinase C (TrkC) from the complementary binding complex, subsequently increasing the protein level of TrkC in GC cells.	mir-128	14-21	neurotrophic receptor tyrosine kinase 3	Homo sapiens	153-157	
31173288-15	2019	CONCLUSIONS: PVT1-214-induced miR-128 repression regulates TrkC to further the progression of GC, indicating that this process will provide a promising therapeutic target in GC.	mir-128	30-37	neurotrophic receptor tyrosine kinase 3	Homo sapiens	59-63	
27695040-3	2016	In mouse and human ALS spinal cord, the reduction of miR-128 that destabilizes TrkC.T1 mRNA results in up-regulated TrkC.T1 and TNF-alpha in astrocytes.	mir-128	53-60	neurotrophic receptor tyrosine kinase 3	Homo sapiens	79-83	
27695040-3	2016	In mouse and human ALS spinal cord, the reduction of miR-128 that destabilizes TrkC.T1 mRNA results in up-regulated TrkC.T1 and TNF-alpha in astrocytes.	mir-128	53-60	neurotrophic receptor tyrosine kinase 3	Homo sapiens	116-120